Benchmark raised the firm’s price target on Marcus (MCS) to $25 from $22 and keeps a Buy rating on the shares. After having recently concluded a non-deal roadshow with the executive team, the firm believes the company’s theatrical segment is poised to be a key area of growth in the coming years, the analyst tells investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCS: